US 10550391
Organic compositions to treat beta-ENaC-related diseases
granted A61KA61K31/713A61P
Quick answer
US patent 10550391 (Organic compositions to treat beta-ENaC-related diseases) held by Arrowhead Pharmaceuticals, Inc. expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/713, A61P, A61P1/00, A61P1/18